200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 84611-23-4

84611-23-4

84611-23-4 | Erdosteine

CAS No: 84611-23-4 Catalog No: AG003PY1 MDL No:MFCD00867664

Product Description

Catalog Number:
AG003PY1
Chemical Name:
Erdosteine
CAS Number:
84611-23-4
Molecular Formula:
C8H11NO4S2
Molecular Weight:
249.3072
MDL Number:
MFCD00867664
SMILES:
O=C(NC1CCSC1=O)CSCC(=O)O

Literature

Title Journal
Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins. Toxicology and applied pharmacology 20151015
Effects of erdosteine on cyclosporin-A-induced nephrotoxicity. Human & experimental toxicology 20120601
Effects of erdosteine on hemostasis: an experimental study. Human & experimental toxicology 20120601
Antioxidant pharmacological therapies for COPD. Current opinion in pharmacology 20120601
Pharmacological antioxidant strategies as therapeutic interventions for COPD. Biochimica et biophysica acta 20120501
Is intratympanic injection of erdosteine protective against cisplatin-induced ototoxicity? Neurotoxicity research 20120401
Protective effect of erdosteine against cisplatin-induced ototoxicity in a guinea pig model. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20120401
Caffeic acid phenethyl ester protects 661W cells from H2O2-mediated cell death and enhances electroretinography response in dim-reared albino rats. Molecular vision 20120101
Severe drug hypersensitivity induced by erdosteine and doxofylline as confirmed by patch and lymphocyte transformation tests: a case report. Journal of investigational allergology & clinical immunology 20120101
Inhibition of gene expression of organic cation/carnitine transporter and antioxidant enzymes in oxazaphosphorines-induced acute cardiomyopathic rat models. Oxidative medicine and cellular longevity 20120101
Dual effects of erdosteine on hemostasis via its different metabolites in young rats. Human & experimental toxicology 20111001
Comparison of the effects of N-acetyl cysteine and erdosteine in rats with renal injury caused by paracetamol intoxication. Human & experimental toxicology 20110901
The protective effect of erdosteine on radiocontrast induced nephrotoxicity in rats. Environmental toxicology 20110801
[ Erdosteine (Mucodox), oral administration]. Journal de pharmacie de Belgique 20110601
Protective effects of erdosteine on amikacin induced visual evoked potentials and lipid peroxidation alterations. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110401
Effects of erdosteine on cyclosporine-A-induced hepatotoxicity in rats. Drug and chemical toxicology 20110101
Erdosteine affects eicosanoid production in COPD. International journal of clinical pharmacology and therapeutics 20110101
Prevention of pulmonary complications of pneumoperitoneum in rats. Journal of cardiothoracic surgery 20110101
Doxorubicin induced nephrotoxicity: protective effect of nicotinamide. International journal of cell biology 20110101
Prevention of hepatorenal toxicity with Sonchus asper in gentamicin treated rats. BMC complementary and alternative medicine 20110101
Protective effect of erdosteine metabolite I against hydrogen peroxide-induced oxidative DNA-damage in lung epithelial cells. Arzneimittel-Forschung 20110101
Effects of sulphurous water on human neutrophil elastase release. Therapeutic advances in respiratory disease 20101201
Combination antioxidant effect of α-tocoferol and erdosteine in ischemia-reperfusion injury in rat model. International urology and nephrology 20100901
Beneficial effect of erdosteine on methotrexate-induced testicular toxicity in mice. Toxicology and industrial health 20100801
Exaggerated liver injury induced by renal ischemia reperfusion in diabetes: effect of exenatide. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20100701
Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study. Scandinavian journal of gastroenterology 20100601
The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data. Pulmonary pharmacology & therapeutics 20100401
Effectiveness of erdosteine, a second generation mucolytic agent, in children with acute rhinosinusitis: a randomized, placebo controlled, double-blinded clinical study. Acta paediatrica (Oslo, Norway : 1992) 20100401
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. Journal of the National Cancer Institute 20100106
Erdosteine in renal ischemia-reperfusion injury: an experimental study in pigs. The Journal of veterinary medical science 20100101
Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis. Respiratory research 20100101
Free radical scavenging activity of erdosteine metabolite I investigated by electron paramagnetic resonance spectroscopy. Pharmacology 20100101
Ambroxol - Resurgence of an old molecule as an anti-inflammatory agent in chronic obstructive airway diseases. Lung India : official organ of Indian Chest Society 20100101
Association between lung function and exacerbation frequency in patients with COPD. International journal of chronic obstructive pulmonary disease 20100101
Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation. Oxidative medicine and cellular longevity 20100101
Molecular, genetic and epigenetic pathways of peroxynitrite-induced cellular toxicity. Interdisciplinary toxicology 20091201
The protective effect of erdosteine on vancomycin-induced pancreatic damage in rats. Molecular and cellular biochemistry 20091101
Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury. The Journal of surgical research 20090801
Protective effect of sulfhydryl-containing antioxidants against ischemia/reperfusion injury of prepubertal rat intestine. Journal of gastroenterology and hepatology 20090401
Erdosteine modulates radiocontrast-induced hepatotoxicity in rat. Cell biochemistry and function 20090401
Erdosteine: its relevance in COPD treatment. Expert opinion on drug metabolism & toxicology 20090301
The protective effect of erdosteine on short-term global brain ischemia/reperfusion injury in rats. Progress in neuro-psychopharmacology & biological psychiatry 20090201
Environmental toxicity, redox signaling and lung inflammation: the role of glutathione. Molecular aspects of medicine 20090101
[Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin]. Tuberkuloz ve toraks 20090101
Raft of results energizes researchers. IAVI report : newsletter on international AIDS vaccine research 20090101
Simultaneous estimation of Cefixime and Erdosteine in capsule dosage form by spectrophotometric method. Hindustan antibiotics bulletin 20090101
Antioxidant therapeutic advances in COPD. Therapeutic advances in respiratory disease 20081201
The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease. International journal of chronic obstructive pulmonary disease 20081201
Erdosteine for COPD exacerbations. Drug and therapeutics bulletin 20081001
Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD. Therapeutic advances in respiratory disease 20081001
Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats. Toxicology and industrial health 20080901
The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of hippocampal neural cells. Journal of cellular biochemistry 20080801
Effects of erdosteine on acetaminophen-induced hepatotoxicity in rats. Toxicologic pathology 20080701
High-throughput determination of fudosteine in human plasma by liquid chromatography-tandem mass spectrometry, following protein precipitation in the 96-well plate format. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080501
The effects of erdosteine on lung injury induced by the ischemia-reperfusion of the hind-limbs in rats. The Journal of surgical research 20080401
Antioxidant effect of sulphurous thermal water on human neutrophil bursts: chemiluminescence evaluation. Respiration; international review of thoracic diseases 20080101
Changes in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: a controlled study in current smokers with mild COPD. Pulmonary pharmacology & therapeutics 20080101
Renoprotective effect of erdosteine in rats against gentamicin nephrotoxicity: a comparison of 99mTc-DMSA uptake with biochemical studies. Molecular and cellular biochemistry 20080101
Erdosteine: antitussive and anti-inflammatory effects. Lung 20080101
[Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin]. Tuberkuloz ve toraks 20080101
Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression. Journal of inflammation (London, England) 20080101
Antioxidant intervention of smoking-induced lung tumor in mice by vitamin E and quercetin. BMC cancer 20080101
Antioxidant systems and oxidative stress in the testes. Oxidative medicine and cellular longevity 20080101
Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease. Expert review of respiratory medicine 20071201
The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats. Toxicology 20070924
Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities. Digestive diseases and sciences 20070901
Mucoactive agents for airway mucus hypersecretory diseases. Respiratory care 20070901
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study. Clinical therapeutics 20070901
Future therapeutic treatment of COPD: struggle between oxidants and cytokines. International journal of chronic obstructive pulmonary disease 20070901
Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections. International journal of chronic obstructive pulmonary disease 20070901
Examination of lung toxicity, oxidant/antioxidant status and effect of erdosteine in rats kept in coal mine ambience. Environmental toxicology and pharmacology 20070901
Protective effects of erdosteine and vitamins C and E combination on ischemia-reperfusion-induced lung oxidative stress and plasma copper and zinc levels in a rat hind limb model. Biological trace element research 20070701
Protective effects of erdosteine on doxorubicin-induced hepatotoxicity in rats. Archives of medical research 20070501
An overview of erdosteine antioxidant activity in experimental research. Pharmacological research 20070401
Erdosteine treatment attenuates oxidative stress and fibrosis in experimental biliary obstruction. Pediatric surgery international 20070301
The effects of erdosteine, N-acetylcysteine and vitamin E on nicotine-induced apoptosis of cardiac cells. Journal of applied toxicology : JAT 20070101
Clinical effects of erdosteine in the treatment of acute respiratory tract diseases in children. International journal of clinical pharmacology and therapeutics 20070101
Erdosteine ameliorates lung injury induced by transient aortic occlusion in rats. Cardiovascular journal of Africa 20070101
Regulation of sepsis-induced apoptosis of pulmonary cells by posttreatment of erdosteine and N-aceylcysteine. Toxicology 20061207
Pharmacological treatment of chronic obstructive pulmonary disease. International journal of chronic obstructive pulmonary disease 20061201
Protective role of erdosteine on vancomycin-induced oxidative stress in rat liver. Molecular and cellular biochemistry 20061001
Protective effects of N-acetylcysteine and erdosteine on hemorrhagic shock-induced acute lung injury. European journal of emergency medicine : official journal of the European Society for Emergency Medicine 20061001
Erdosteine against acetaminophen induced renal toxicity. Molecular and cellular biochemistry 20060701
Oxidative stress and redox regulation of lung inflammation in COPD. The European respiratory journal 20060701
Antioxidant therapeutic targets in COPD. Current drug targets 20060601
Role of mucolytics in the management of COPD. International journal of chronic obstructive pulmonary disease 20060601
Antioxidant therapies in COPD. International journal of chronic obstructive pulmonary disease 20060301
The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of pulmonary cells. Toxicology 20060215
Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urological research 20060201
Effects of erdosteine on bleomycin-induced lung fibrosis in rats. Molecular and cellular biochemistry 20060101
Comparison of the effects of erdosteine and N-acetylcysteine on apoptosis regulation in endotoxin-induced acute lung injury. Journal of applied toxicology : JAT 20060101
Hypobaric-hypoxia-induced pulmonary damage in rats ameliorated by antioxidant erdosteine. Acta histochemica 20060101
Effect of metabolite I of erdosteine on the release of human neutrophil elastase. Pharmacology 20060101
The protective role of erdosteine on testicular tissue after testicular torsion and detorsion. Molecular and cellular biochemistry 20051201
In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine. Toxicology 20051115
The protective effect of erdosteine against ototoxicity induced by cisplatin in rats. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20051001
Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats. Molecular and cellular biochemistry 20051001
The effects of isoniazid on hippocampal NMDA receptors: protective role of erdosteine. Molecular and cellular biochemistry 20050901
A combination of budesonide and the SH-metabolite I of erdosteine acts synergistically in reducing chemiluminescence during human neutrophil respiratory burst. Pharmacology 20050601
Erdosteine ameliorates PTZ-induced oxidative stress in mice seizure model. Brain research bulletin 20050530
Effects of erdosteine on smoking-induced lipid peroxidation in healthy smokers. Drugs in R&D 20050101
Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine. Pulmonary pharmacology & therapeutics 20050101
Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury. Respiratory research 20050101
Erdosteine ameliorates neurological outcome and oxidative stress due to ischemia/reperfusion injury in rabbit spinal cord. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 20041001
The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacological research 20040901
Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats. Nitric oxide : biology and chemistry 20040901
Protective effects of erdosteine on rotenone-induced oxidant injury in liver tissue. Toxicology and industrial health 20040901
Inhibitory effects of metabolite I of erdosteine on the generation of nitric oxide and peroxynitrite chemiluminescence by human neutrophils. Pharmacology 20040701
Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats. European journal of pharmacology 20040628
Sensitive determination of erdosteine in human plasma by use of automated 96-well solid-phase extraction and LC-MS/MS. Journal of pharmaceutical and biomedical analysis 20040218
In vivo evidence suggesting a role for purine-catabolizing enzymes in the pathogenesis of cisplatin-induced nephrotoxicity in rats and effect of erdosteine against this toxicity. Cell biochemistry and function 20040101
Erdosteine improves oxidative damage in a rat model of renal ischemia-reperfusion injury. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20040101
Cisplatin-induced acute renal failure is ameliorated by erdosteine in a dose-dependent manner. Journal of applied toxicology : JAT 20040101
Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC pharmacology 20040101
The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study. Drugs under experimental and clinical research 20040101
Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]. BMC pulmonary medicine 20040101
Erdosteine prevents doxorubicin-induced cardiotoxicity in rats. Pharmacological research 20031001
The activities of tissue xanthine oxidase and adenosine deaminase and the levels of hydroxyproline and nitric oxide in rat hearts subjected to doxorubicin: protective effect of erdosteine. Toxicology 20030930
Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats. Pharmacological research 20030401
Depressant effects of ambroxol and erdosteine on cytokine synthesis, granule enzyme release, and free radical production in rat alveolar macrophages activated by lipopolysaccharide. Pharmacology & toxicology 20030401
Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacological research 20030201
Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. Journal of applied toxicology : JAT 20030101
Effects on the reactive oxygen species of erdosteine and its metabolite in vitro. Arzneimittel-Forschung 20020101
The combination of the SH metabolite of erdosteine (a mucoactive drug) and ciprofloxacin increases the inhibition of bacterial adhesiveness achieved by ciprofloxacin alone. Drugs under experimental and clinical research 20020101
The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophils. Drugs under experimental and clinical research 20020101
Bacterial adhesiveness: effects of the SH metabolite of erdosteine (mucoactive drug) plus clarithromycin versus clarithromycin alone. Chemotherapy 20010101

Related Products

© 2019 Angene International Limited. All rights Reserved.